Walgreens Boots: Q2 EPS falls 27%
(CercleFinance.com) - Walgreens Boots Alliance says its Q2 adjusted EPS fell 27.
2% to $1.16 (-25.8% at constant currency), reflecting a 26% headwind from lower Covid-19 vaccine and testing volumes.
At $34.9bn, sales grew by 3.3%, including a 4.5% increase at constant currency. The leading US retail pharmacy segment reported a 3.1% LFL increase in sales.
WBA said it completed a strong Q2, with an acceleration in February, which reinforces its confidence in continued strong growth in H2.
The group is maintaining its FY adjusted EPS guidance range of $4.45 to $4.65, with strong core business growth more than offset by the effect of the Covid-19 demand spike.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
2% to $1.16 (-25.8% at constant currency), reflecting a 26% headwind from lower Covid-19 vaccine and testing volumes.
At $34.9bn, sales grew by 3.3%, including a 4.5% increase at constant currency. The leading US retail pharmacy segment reported a 3.1% LFL increase in sales.
WBA said it completed a strong Q2, with an acceleration in February, which reinforces its confidence in continued strong growth in H2.
The group is maintaining its FY adjusted EPS guidance range of $4.45 to $4.65, with strong core business growth more than offset by the effect of the Covid-19 demand spike.
Copyright (c) 2023 CercleFinance.com. All rights reserved.